117 related articles for article (PubMed ID: 8960370)
1. Expression, subcellular distribution and plasma membrane binding of cathepsin B and gelatinases in bone metastatic tissue.
Arkona C; Wiederanders B
Biol Chem; 1996 Nov; 377(11):695-702. PubMed ID: 8960370
[TBL] [Abstract][Full Text] [Related]
2. Proteases as prognostic markers in cancer.
Duffy MJ
Clin Cancer Res; 1996 Apr; 2(4):613-8. PubMed ID: 9816210
[TBL] [Abstract][Full Text] [Related]
3. "In vitro" study of basement membrane degradation by the cysteine proteinases, cathepsins B, B-like and L. Digestion of collagen IV, laminin, fibronectin, and release of gelatinase activities from basement membrane fibronectin.
Guinec N; Dalet-Fumeron V; Pagano M
Biol Chem Hoppe Seyler; 1993 Dec; 374(12):1135-46. PubMed ID: 8129860
[TBL] [Abstract][Full Text] [Related]
4. Possible contribution of active MMP2 to lymph-node metastasis and secreted cathepsin L to bone invasion of newly established human oral-squamous-cancer cell lines.
Kawamata H; Nakashiro K; Uchida D; Harada K; Yoshida H; Sato M
Int J Cancer; 1997 Jan; 70(1):120-7. PubMed ID: 8985100
[TBL] [Abstract][Full Text] [Related]
5. Characterizing human colorectal carcinomas by proteolytic profile.
Murnane MJ; Shuja S; Del Re E; Cai J; Iacobuzio-Donahue C; Klepeis V
In Vivo; 1997; 11(3):209-16. PubMed ID: 9239513
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of cathepsin B and urokinase plasminogen activator is associated with increased risk of recurrence and metastasis in patients with chondrosarcoma.
Häckel CG; Krueger S; Grote HJ; Oshiro Y; Hodges S; Johnston DA; Johnson ME; Roessner A; Ayala AG; Czerniak B
Cancer; 2000 Sep; 89(5):995-1003. PubMed ID: 10964329
[TBL] [Abstract][Full Text] [Related]
7. Cathepsins B and L in synovial fluids from patients with rheumatoid arthritis and the effect of cathepsin B on the activation of pro-urokinase.
Ikeda Y; Ikata T; Mishiro T; Nakano S; Ikebe M; Yasuoka S
J Med Invest; 2000 Feb; 47(1-2):61-75. PubMed ID: 10740981
[TBL] [Abstract][Full Text] [Related]
8. Cysteine endopeptidases and their inhibitors in malignant progression of rat embryo fibroblasts.
Sloane BF; Rozhin J; Moin K; Ziegler G; Fong D; Muschel RJ
Biol Chem Hoppe Seyler; 1992 Jul; 373(7):589-94. PubMed ID: 1515088
[TBL] [Abstract][Full Text] [Related]
9. Protein restriction influences glomerular matrix turnover and tubular hypertrophy by modulation of renal proteinase activities.
Schaefer L; Meier K; Häfner C; Teschner M; Heidland A; Schaefer RM
Miner Electrolyte Metab; 1996; 22(1-3):162-7. PubMed ID: 8676812
[TBL] [Abstract][Full Text] [Related]
10. Differential secretion of cathepsins B and L from normal and tumor human lung cells stimulated by 12(S)-hydroxy-eicosatetraenoic acid.
Ulbricht B; Hagmann W; Ebert W; Spiess E
Exp Cell Res; 1996 Aug; 226(2):255-63. PubMed ID: 8806429
[TBL] [Abstract][Full Text] [Related]
11. Cysteine proteinases in chondrosarcomas.
Söderström M; Ekfors T; Böhling T; Aho A; Aro HT; Vuorio E
Matrix Biol; 2001 Jan; 19(8):717-25. PubMed ID: 11223331
[TBL] [Abstract][Full Text] [Related]
12. Immunodetection of cathepsins B and L present in and secreted from human pre-malignant and malignant colorectal tumour cell lines.
Maciewicz RA; Wardale RJ; Etherington DJ; Paraskeva C
Int J Cancer; 1989 Mar; 43(3):478-86. PubMed ID: 2647640
[TBL] [Abstract][Full Text] [Related]
13. The malignant phenotype and cysteine proteinases.
Sloane BF; Rozhin J; Krepela E; Ziegler G; Sameni M
Biomed Biochim Acta; 1991; 50(4-6):549-54. PubMed ID: 1801721
[TBL] [Abstract][Full Text] [Related]
14. Increased expression of cathepsins L and B and decreased activity of their inhibitors in metastatic, ras-transformed NIH 3T3 cells.
Chambers AF; Colella R; Denhardt DT; Wilson SM
Mol Carcinog; 1992; 5(3):238-45. PubMed ID: 1586450
[TBL] [Abstract][Full Text] [Related]
15. Control of type IV collagenase activity by components of the urokinase-plasmin system: a regulatory mechanism with cell-bound reactants.
Mazzieri R; Masiero L; Zanetta L; Monea S; Onisto M; Garbisa S; Mignatti P
EMBO J; 1997 May; 16(9):2319-32. PubMed ID: 9171346
[TBL] [Abstract][Full Text] [Related]
16. Interaction of lysosomal cysteine proteinases with alpha 2-macroglobulin: conclusive evidence for the endopeptidase activities of cathepsins B and H.
Mason RW
Arch Biochem Biophys; 1989 Sep; 273(2):367-74. PubMed ID: 2476070
[TBL] [Abstract][Full Text] [Related]
17. [Proteolytic enzymes in human lymphocytic leukemia cells. I. Activity of dipeptidylaminopeptidase IV, plasminogen activator and cathepsins B and L in cells with different immunologic phenotype].
Lokshina LA; Bylinkina VS; Samoĭlova RS; Gureeva TA; Golubeva NV; Polianskaia AM
Biokhimiia; 1993 Jul; 58(7):1104-15. PubMed ID: 8103371
[TBL] [Abstract][Full Text] [Related]
18. Increases in cathepsins B and L and thiol proteinase inhibitor in muscle of dystrophic hamsters. Their localization in invading phagocytes.
Kominami E; Bando Y; Ii K; Hizawa K; Katunuma N
J Biochem; 1984 Dec; 96(6):1841-8. PubMed ID: 6530400
[TBL] [Abstract][Full Text] [Related]
19. Properties of a plasma membrane-associated cathepsin B-like cysteine proteinase in metastatic B16 melanoma variants.
Rozhin J; Robinson D; Stevens MA; Lah TT; Honn KV; Ryan RE; Sloane BF
Cancer Res; 1987 Dec; 47(24 Pt 1):6620-8. PubMed ID: 2824039
[TBL] [Abstract][Full Text] [Related]
20. Membrane-associated cathepsin L: a role in metastasis of melanomas.
Rozhin J; Wade RL; Honn KV; Sloane BF
Biochem Biophys Res Commun; 1989 Oct; 164(1):556-61. PubMed ID: 2803319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
